Cargando…

User Preferences in a Carrageenan-Based Vaginal Drug Delivery System

Topical microbicides are a promising solution to address the global threat of HIV and other sexually transmitted infections. To be successful, a microbicide not only needs to be biologically functional but also highly acceptable to users. User acceptability of microbicides can be incorporated early...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bangde, Zaveri, Toral, Ziegler, Gregory R., Hayes, John E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554666/
https://www.ncbi.nlm.nih.gov/pubmed/23358688
http://dx.doi.org/10.1371/journal.pone.0054975
_version_ 1782256948161282048
author Li, Bangde
Zaveri, Toral
Ziegler, Gregory R.
Hayes, John E.
author_facet Li, Bangde
Zaveri, Toral
Ziegler, Gregory R.
Hayes, John E.
author_sort Li, Bangde
collection PubMed
description Topical microbicides are a promising solution to address the global threat of HIV and other sexually transmitted infections. To be successful, a microbicide not only needs to be biologically functional but also highly acceptable to users. User acceptability of microbicides can be incorporated early in the product formulation and design process. Previous qualitative research revealed women had strong preferences regarding product shape, while preferences related to size and firmness were less clear. Here, we explored the effect of size and firmness on the acceptability of semisolid ovoid microbicide prototypes intended for vaginal use. Sexually active women (n = 74) were randomized to one of two conditions: with and without applicator. Nine different prototypes were evaluated; they were formulated to low, medium and high firmness using mixtures of kappa and iota carrageenan and potassium chloride. Three sizes were produced at each firmness level. Women manipulated all nine prototypes, rating them for perceived effectiveness, imagined ease-of-insertion and willingness-to-try on visual analog scales. The influence of size and firmness on these three outcome measures were assessed using ANOVA and response surface models. Results indicated size and firmness both influenced the outcome measures, but firmess was more influential than size. Also, the specific effects of size and firmness depended strongly on presence or absence of an applicator. Generally, women in the without applicator condition wanted a larger, firmer product. Collectively, these data suggest efforts to rationally design of microbicides for enhanced user acceptability must consider factors like size and firmness. Also, the decision to include or forego an applicator should be addressed early in the design process, as it strongly influences other design decisions.
format Online
Article
Text
id pubmed-3554666
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35546662013-01-28 User Preferences in a Carrageenan-Based Vaginal Drug Delivery System Li, Bangde Zaveri, Toral Ziegler, Gregory R. Hayes, John E. PLoS One Research Article Topical microbicides are a promising solution to address the global threat of HIV and other sexually transmitted infections. To be successful, a microbicide not only needs to be biologically functional but also highly acceptable to users. User acceptability of microbicides can be incorporated early in the product formulation and design process. Previous qualitative research revealed women had strong preferences regarding product shape, while preferences related to size and firmness were less clear. Here, we explored the effect of size and firmness on the acceptability of semisolid ovoid microbicide prototypes intended for vaginal use. Sexually active women (n = 74) were randomized to one of two conditions: with and without applicator. Nine different prototypes were evaluated; they were formulated to low, medium and high firmness using mixtures of kappa and iota carrageenan and potassium chloride. Three sizes were produced at each firmness level. Women manipulated all nine prototypes, rating them for perceived effectiveness, imagined ease-of-insertion and willingness-to-try on visual analog scales. The influence of size and firmness on these three outcome measures were assessed using ANOVA and response surface models. Results indicated size and firmness both influenced the outcome measures, but firmess was more influential than size. Also, the specific effects of size and firmness depended strongly on presence or absence of an applicator. Generally, women in the without applicator condition wanted a larger, firmer product. Collectively, these data suggest efforts to rationally design of microbicides for enhanced user acceptability must consider factors like size and firmness. Also, the decision to include or forego an applicator should be addressed early in the design process, as it strongly influences other design decisions. Public Library of Science 2013-01-24 /pmc/articles/PMC3554666/ /pubmed/23358688 http://dx.doi.org/10.1371/journal.pone.0054975 Text en © 2013 Li et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Li, Bangde
Zaveri, Toral
Ziegler, Gregory R.
Hayes, John E.
User Preferences in a Carrageenan-Based Vaginal Drug Delivery System
title User Preferences in a Carrageenan-Based Vaginal Drug Delivery System
title_full User Preferences in a Carrageenan-Based Vaginal Drug Delivery System
title_fullStr User Preferences in a Carrageenan-Based Vaginal Drug Delivery System
title_full_unstemmed User Preferences in a Carrageenan-Based Vaginal Drug Delivery System
title_short User Preferences in a Carrageenan-Based Vaginal Drug Delivery System
title_sort user preferences in a carrageenan-based vaginal drug delivery system
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554666/
https://www.ncbi.nlm.nih.gov/pubmed/23358688
http://dx.doi.org/10.1371/journal.pone.0054975
work_keys_str_mv AT libangde userpreferencesinacarrageenanbasedvaginaldrugdeliverysystem
AT zaveritoral userpreferencesinacarrageenanbasedvaginaldrugdeliverysystem
AT zieglergregoryr userpreferencesinacarrageenanbasedvaginaldrugdeliverysystem
AT hayesjohne userpreferencesinacarrageenanbasedvaginaldrugdeliverysystem